
Daiwa Securities Downgrades Bristol-Myers Squibb Co (BMY) to a Neutral from an Outperform
Bristol-Myers Squibb Co’s recent filing unveils that its EVP, Chief Financial Officer Elkins David V unloaded Company’s shares for reported
Bristol-Myers Squibb Co’s recent filing unveils that its EVP, Chief Financial Officer Elkins David V unloaded Company’s shares for reported
Bristol-Myers Squibb Co’s recently made public that its Officer Elkins David V acquired Company’s shares for reported $2.65 million on
In a filing, Bristol-Myers Squibb Co revealed its EVP, Corporate Affairs Short Bartie Wendy unloaded Company’s shares for reported $16719.0
Bristol-Myers Squibb Co’s recently made public that its EVP, Corporate Affairs Short Bartie Wendy unloaded Company’s shares for reported $16719.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Bristol-Myers Squibb Co’s filing revealed that its EVP, Corporate Affairs Short Bartie Wendy unloaded Company’s shares for reported $16719.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bristol-Myers Squibb
Bristol-Myers Squibb Co’s recent filing unveils that its President, RayzeBio Org. Hickey Benjamin unloaded Company’s shares for reported $3702.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bristol-Myers Squibb